semaglutide india brands 50+ Branded Generics To Enter As Diabetes Drug Patent Expires In March 2026 Semaglutide Market Shifts in India:

Serious reactions are extremely rare, especially when injections are performed by licensed medical professionals

Novo Nordisks patent disputes with generic drug makers (Viatris, its subsidiary Mylan, and Natco Pharma) ended this way in 2024

The Health Benefits Beyond Weight Loss: GLP-1 and Metabolic Health GLP-1 therapy does more than just help with weight loss

Hepatology 2010;51:100716 [DOI] [PMC free article] [PubMed] [Google Scholar] 105.Liang H, Feng Y, Cui R, Qiu M, Zhang J, Liu C.Simvastatin protects against acetaminophen-induced liver injury in mice

The clinical trial numbers The STEP trial program the most comprehensive clinical evidence for semaglutide's weight loss effects enrolled thousands of patients across multiple countries over 68 weeks

How can you manage a tirzepatide headache